What is the quality of the evidence for the relative effect of mineralocorticoid receptor antagonists versus placebo for heart failure with reduced ejection fraction?
The quality of the evidence for the relative effect of mineralocorticoid receptor antagonists versus placebo for heart failure with reduced ejection fraction is generally very low due to inconsistency, indirectness, imprecision, risk of bias, and/or imprecision.